Wolverine Trading, LLC Roivant Sciences Ltd. Transaction History
Wolverine Trading, LLC
- $103 Billion
- Q4 2024
A detailed history of Wolverine Trading, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Wolverine Trading, LLC holds 19,600 shares of ROIV stock, worth $215,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,600Holding current value
$215,600% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
326Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$724 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$683 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$526 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$485 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$389 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.75B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...